Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Anacor patents LeuRS inhibitors for tuberculosis

Feb. 27, 2015

Duke University patent describes LpxC inhibitors

Feb. 27, 2015

Merck & Co. synthesizes new orexin OX2 receptor antagonists

Feb. 26, 2015

Wee1-like protein kinase inhibitors prepared and tested at Almac Discovery

Feb. 26, 2015

Roche patents compounds for treatment of RSV

Feb. 26, 2015

Takeda describes FFA1 receptor agonists for diabetes

Feb. 26, 2015

Fujian Haixi Pharmaceuticals patent reports development of BTK inhibitors

Feb. 26, 2015

New orexin receptor antagonists disclosed by Merck & Co.

Feb. 25, 2015

Takeda patent reveals prokineticin PKR1 receptor antagonists

Feb. 25, 2015

Galapagos patents CFTR modulators

Feb. 25, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...